Chimeric Therapeutics Limited (ASX:CHM)
0.0050
0.00 (0.00%)
Apr 24, 2025, 3:06 PM AEST
Chimeric Therapeutics Market Cap
Chimeric Therapeutics has a market cap or net worth of 8.10 million as of April 24, 2025. Its market cap has decreased by -65.83% in one year.
Market Cap
8.10M
Enterprise Value
3.03M
Revenue
2.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since January 18, 2021, Chimeric Therapeutics's market cap has decreased from 97.50M to 8.10M, a decrease of -91.69%. That is a compound annual growth rate of -44.19%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2025 | 8.10M | -26.52% |
Dec 31, 2024 | 11.02M | -56.60% |
Dec 29, 2023 | 25.40M | -27.35% |
Dec 30, 2022 | 34.97M | -59.93% |
Dec 31, 2021 | 87.26M | -10.51% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 116.09B |
Pro Medicus | 21.80B |
Cochlear | 17.34B |
Sonic Healthcare | 12.28B |
Telix Pharmaceuticals | 9.57B |
Ramsay Health Care | 7.68B |
Ansell | 4.29B |
Mesoblast | 2.17B |